These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25220556)

  • 21. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
    Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S
    Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population - A prospective, multi-center, observational study (BLAST 1).
    Chua NG; Loo L; Hee DKH; Lim TP; Ng TM; Hoo GSR; Soong JL; Ong JCL; Tang SSL; Zhou YP; Lee W; Lee LS; Cove M; Ling LM; Kwa AL
    J Crit Care; 2022 Apr; 68():107-113. PubMed ID: 34999376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad-spectrum β-lactams in obese non-critically ill patients.
    Hites M; Taccone FS; Wolff F; Maillart E; Beumier M; Surin R; Cotton F; Jacobs F
    Nutr Diabetes; 2014 Jun; 4(6):e119. PubMed ID: 24956136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
    Gonçalves-Pereira J; Póvoa P
    Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.
    Wong G; Taccone F; Villois P; Scheetz MH; Rhodes NJ; Briscoe S; McWhinney B; Nunez-Nunez M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2020 Feb; 75(2):429-433. PubMed ID: 31665353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
    Wolff F; Deprez G; Seyler L; Taccone F; Hites M; Gulbis B; Vincent JL; Jacobs F; Cotton F
    Talanta; 2013 Jan; 103():153-60. PubMed ID: 23200371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
    Alobaid AS; Brinkmann A; Frey OR; Roehr AC; Luque S; Grau S; Wong G; Abdul-Aziz MH; Roberts MS; Lipman J; Roberts JA
    J Antimicrob Chemother; 2016 Mar; 71(3):696-702. PubMed ID: 26702922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
    Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
    Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use.
    Ribera A; Soldevila L; Rigo-Bonnin R; Tubau F; Padullés A; Gómez-Junyent J; Ariza J; Murillo O
    Infection; 2018 Apr; 46(2):239-244. PubMed ID: 29363049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A microbiological method for determining serum levels of broad spectrum β-lactam antibiotics in critically ill patients.
    Fridlund J; Woksepp H; Schön T
    J Microbiol Methods; 2016 Oct; 129():23-27. PubMed ID: 27469351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients.
    Polain A; Gorham J; Romeo I; Belliato M; Peluso L; Partipilo F; Njimi H; Brasseur A; Jacobs F; Creteur J; Hites M; Taccone FS
    Microorganisms; 2021 Oct; 9(11):. PubMed ID: 34835344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are β-lactam concentrations adequate in severe sepsis and septic shock in children?
    Chosidow A; Benaboud S; Beranger A; Zheng Y; Moulin F; Dupic L; Renolleau S; Treluyer JM; Oualha M
    Therapie; 2020; 75(6):633-640. PubMed ID: 32593420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
    Delattre IK; Musuamba FT; Verbeeck RK; Dugernier T; Spapen H; Laterre PF; Wittebole X; Cumps J; Taccone FS; Vincent JL; Jacobs F; Wallemacq PE
    Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J
    Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit Patients.
    Schießer S; Hitzenbichler F; Kees MG; Kratzer A; Lubnow M; Salzberger B; Kees F; Dorn C
    Ther Drug Monit; 2021 Apr; 43(2):264-270. PubMed ID: 33086362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.